Quantitative Screening for Benzodiazepines in Blood by Dual-Column Gas Chromatography and Comparison of the Results with Urine Immunoassay*
|
|
- Andrea Harper
- 6 years ago
- Views:
Transcription
1 Quantitative Screening for Benzodiazepines in Blood by Dual-Column Gas Chromatography and Comparison of the Results with Urine Immunoassay* Ilpo Rasanen, Ilkka Ojanpedi, and Erkki Vuori Department of Forensic Medicine, P.O. Box 40, F/N-O0014 Universi~/ of Helsinki, Finland [ Abstract [ A dual-column retention index method is described for quantitative gas chromatographic (GC) screening of 26 benzodiazepine drugs and metabolites in the blood using DB-5 and DB-17 capillary columns and electron capture detection. The method involves a one-step, smau-scale liquid-liquid extraction with ethyl acetate and derivatization with N-methyI-N-(tert-bulyldimethylsilyl)trifluoroacetamide with 1% tert-butyldimethylsilyl chloride. The results from the GC screening of 514 postmortem blood samples were compared to those obtained from urine immunoassay (Syva ETSplus with a 200-ng/mL cutoff). Both methods gave a negative result in 284 cases and a positive result in 149 cases. In 48 cases, urine was negative by immunoassay but blood was positive by GC. The opposite situation (blood negative, urine positive) was detected only in four cases. In 29 cases, an invalid result was obtained by urine by immunoassay: 26 blood samples of those cases were negative and three samples positive by GC. In postmortem forensic toxicology, the present GC method seems to be a good alternative to the common combination of urinary immunoassay followed by quantitative analysis of blood by chromatography. Introduction In urinary drug testing, the presence of benzodiazepines is usually revealed by screening urine samples by immunochemical techniques and confirming positive findings by chromatographic methods. In postmortem toxicology and in drugs and driving investigations, it is also necessary to perform a quantitative benzodiazepine determination of the blood in order to estimate the degree of toxicity. Although several methods, especially gas chromatography-mass spectrometry (GC-MS), have been published to detect benzodiazepines in urine (I-15), there are fewer methods for a broad range quantitative screening analysis in the whole blood. These methods ' Presented in pan at the SOFT-TIAFT meeting, AJl~Jquerque, New Mexico, October mainly involve gas chromatography (GC) (16-20) or liquid chromatography (HPLC) (21-24). By using GC methods, benzodiazepines are usually analyzed separately from other drugs because of their distinctive chromatographic properties. Benzodiazepines are fairly polar compounds with low volatility and low blood concentrations, and an electron withdrawing group makes them especially amenable to electron capture (EC) detection. Because of their polarity, many benzodiazepines and particularly their metabolites are difficult to analyze at low levels without derivatization of the active hydroxyl or amide groups. The present paper describes a quantitative dual-column GC retention index (RI) method for screening benzodiazepines in the blood and compares the performance of the GC blood analysis with a urine immunoassay in 514 successive postmortem cases. Materials and Methods Reagents N-MethyI-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) with 1% tert-butyldimethylsilyl chloride fib- DMSCI) was from Aldrich (Steinheim, Germany). AquaSil T~ siliconizing fluid was from Pierce (Rockford, IL). [~-Glu" curonidase from E. coli K 12 was from Boehringer MannheiW (Mannheim, Germany). Alprazolam, 1-hydroxyalprazolam, tri" azolam, and 1-hydroxytriazolam were from Upjohn (Kala" mazoo, MI). Bromazepam, desmethyldiazepam, lorazepam, Iormetazepam, and prazepam were from Sigma (St. LouiS, MO). Brotizolam was from Boehringer Ingelheim (Ingelhei~ am Rhein, Germany). Clobazam and norclobazam were fro~ Hoechst AG (Frankfurt am Main, Germany). Clonazepam, 7- I aminoclonazepam, chlordiazepoxide, demoxepam, fluni" trazepam, desmethylflunitrazepam, flurazepam, midazolaro, and 1-hydroxymidazolam were from Hoffman-La Roche (Basel, Switzerland). Diazepam, nitrazepam, oxazepam, and temazepam were from Orion (Espoo, Finland). Phenazepa~ 46 Reproduction (photocopying) of editorial content of this journal is prohibited without publisher's permission.
2 was a donation from the Republican Centre of Forensic Medicine (Moscow, Russia). The R-series RI standards (Figure 1) were synthesized in the authors' laboratory (25). The compounds R2, R6, R8, R12, R14, and R16 were used as qualitative standards for calculating the retention index values of unknown peaks. R2, structurally closest to the benzodiazepine drugs, was also used as a quantitative internal standard. F Figure I. The structures of the R-series retention index standards. R = alkyl (R2: R = ethyl, R6: R = hexyl, elc.) R. The stock standard solutions were prepared by weighing each of the pure substances into a 4-rnL vial and adding methanol (acetonitrile for norclobazarn) in order to obtain a concentration of 1 mg/ml. The stock solutions were further diluted with methanol (norclobazam solution with acetonitrile) to obtain working solutions of 100, 10, and 1 IJg/mL. Sample preparation for GC and GC-MS The centrifuge tubes were silanized before use by dipping them into a 0.2% solution of Aquasil in water, rinsing with water, and allowing to dry at room temperature for 24 h. The working blood standards were prepared by adding the standard solutions into centrifuge tubes (three or four compounds per one tube) and evaporating the solvent to dryness under a gentle stream of nitrogen. Whole blood (bovine blood for working blood standards) (1 g) was transferred into a centrifuge tube (10-ram i.d.). The internal standard 1,3-dihydro-l-ethyi-7-fluoro-5-(4-fluorophenyl)-2H-1,4-benzodiazepin-2-one (R2) (0.3 Ilg) in methanol (50 I~L) and saturated ammonium chloride solution (0.5 ml) were added to obtain a ph of 7.4, and the mixture was shaken. The sample was extracted with ethyl acetate (0.5 ml) in a vortex mixer for 5 rain and centrifuged. An aliquot of Table I. Retention Indices, Linearity, Limit of Detection (LOD), and Limit of Quantitation (LOQ) RI' RI' Range r 2 r 2 LOD LOQ ~ Working blood Substance DB-5 DB-17 (ng/g) DB-5 DB-17 (ng/g) (ng/g) standards (ng/g*) Diazepam , 800, 1500 Desmethyldiazepam.TBDMS , 1000, 2000 Clobazam , 500, 1000 Midazolam , 500, 1000 Norclobazam-TBDMS , 1000, 2000 Flunitrazepam , 20, 50 Prazepam I I0 15 I0, 50, I00 Brornazepam.TBDMS , 500, 1000 Chlordiazepoxide1.TBDMS w 4~ , 2000, 5000 Chlordiazepoxide2.TBDMS Phenazepam-TBDMS I0 50, 200, 500 Desmethylflunitrazepam.TBDMS , 20, 50 Nitrazepam-TBDMS , 300, 500 Oxazepam-TBDMS , 1000, 2000 Demoxepam-TBDMS ' , 1000, 2000 Flurazepam I I , 50, 200 Temazepam-TBDMS I0 200, 800, "Aminoclonazepam.TBDMS w , 50, 200 Clonazepam.TBDMS , 50, 200 l-ormetazepam.tbdms , 20, 50 lorazepam-tbdms , 500, 1000 Alprazolam , I00, 200 I "Hydroxymidazolam-TBDMS , 100, 300 Triazolam I I0 I0, 50, I00 Brolizolam I0 I0, 50, I00 1-Hydroxyalprazolam_TBDMS , 100, Hydroxytriazolam.TBDMS I0 15 I0, 30, 50 El values are delermined T with a new,',akr hof columns and may slightly e differ from those in Table III and Figure 3. V~lues are based on the EURACHEM approach and are measured wilh a different set of samples thus slightly differing from lhe lower limit of linearity. ~r~ ~ u. are based on ~'-.e~r... ty, u..:~dl~: L... u,i~,,. i~,,.j,:.~ n~ u,,,,~r,k~,4 u- g, and r ea blood concentrallons " in forenstc ' ' cases...~ aljlative result only. 47
3 the organic phase (100 ~tl) was transferred to an autosampler vial (07-CPV(A), Chromacol, Trumbull, CT) and evaporated to dryness in order to eliminate the traces of water in ethyl acetate that disturb the silylation procedure. The residue was reconstituted with 100 IJL of ethyl acetate, and 50 IlL of MTBSTFA with 196 TBDMSCI was added. The vial was capped with a crimp cap (8-AC5, Chromacol) and heated at 85~ for 30 rain. Urine samples were hydrolyzed by adding 10 pl of [3-glucuronidase to 1 ml of urine and heating for 40 min at 40~ The rest of the sample preparation procedure was identical to the procedure for blood samples. GC The GC was a Micromat HRGC 412 (HNU-Nordion, Helsinki, Finland) with two EC detectors. The fused silica capillary columns were DB-5 (15 m x 0.32-mm i.d., 0.1-~tm film thickness) and DB-17 (15 m x 0.32-ram i.d., am film thickness, J&W Scientific, Folsom, CA). The columns entered a single injector through a two-hole ferrule. The Grob-type split/splitless injector was operated in the splitless mode. Silanized glass wool was used inside the liner. Automated injections were performed with a CTC A200S autosampler (CTC Analytics, Zwingen, Switzerland) using a 1.5-pL apparent injection volume. The autosampler was set to take the RI standards in ethyl acetate from a separate vial prior to the sample injection. The carrier gas was helium with a flow rate of approximately 3.0 ml/min for DB-5 and 2.0 mumin for DB-17 (130~ The split flow rate was 15 ml/min, and the septum purge flow rate 3 ml/min. The detector makeup gas (5% CH4 in At) flow rate was 25 ml/min. The injector and detector temperatures were 250~ and 300~ respectively. The splitless time was 0.6 rain. The oven temperature was initially held at 130~ for 0.6 rain, increased by 25~ to 220~ and then increased by 5~ to 290~ which was held for 2 rain. GC-MS GC--MS was performed with a Hewlett-Packard (Wilmington, DE) 5972 mass selective detector coupled to a HP 5890 series I1 GC equipped with a HP-1 (12 m x 0.20-ram i.d., 0.33-pro film thickness) capillary column. The GC-MS was operated by Chemstation software and the GC was used in the splitless mode. The injector port temperature was 250~ and the transfer line temperature was 280~ The oven temperature was initially held at 130~ for 0.5 rain and then increased by 15~ to 300~ which was held for 2 min. Data processing in GC Data processing was performed with MS Windows-based SC- WorkStation 3.0 software (Sunicom, Helsinki, Finland). The program was set to automatically identify the internal RI standards by pattern recognition, to calculate the temperature programmed (linear polygonal) RI values of all detected peaks, and to compare them with library data (substance windows). A part of the SC-Workstation, the SC-Compare 1.11 software, first identifies all substances in the library that could match a peak, separately on each column. It then compares the data from the single columns and reports only those substances that were identified with both columns in an easily interpretable form (26). Urine immunoassay Urine samples were centrifuged and the supernatants were analyzed by Emit d.a.u. TM (ETSplus) benzodiazepine assay (Syva, San Jose, CA) using a 200-ng/mL cutoff value. Postmortem specimens For the blood-urine comparison study, 514 successive postmortem cases in which both peripheral blood and urine was sent for toxicological analysis by the medical examiners were used. Results The GC RI values of 26 benzodiazepine drugs and metabolites and the linearity of quantitation, limit of detection, and limit of quantitation in the blood are presented in Table I. The linearity was good on both columns, the r 2 exceeding 0.99, except for chlordiazepoxide, which decomposed producing several peaks. All the compounds could be detected at the therapeutic level and most of them at the low therapeutic level. A concentration in the blood that resulted in a signal three times the baseline noise was used as the criterion for the limit of detection. The EURACHEM approach with 10% precision was used for the calculation of the limit of quantitation. In the EURACHEM approach, samples of decreasing amounts of the analyte are injected six times. The calculated relative standard deviation is plotted against the analyte amount, and the amount that corresponds to the previously defined required precision is equal to the limit of quantitation (27). The extraction recovery was over 80% for each compound. The recoveries were determined by comparing values obtained with unextracted and extracted standards. An unextracted standard was used as a 100% recovery reference. Three blood samples containing the middle concentration of working blood Table II. Quantitative Precision of Selected Compounds Extracted from Blood Theoretical Concentration Mean* Substance (pg/g) (pg/~ cv% Desmethyldiazepam-TBDMS Diazepam Temazepam-TBDMS Midazolam * Values are mean values from two columns and are based on four determination: during a four-week period. 48
4 standards for each compound (Table I) were extracted normally except that the internal standard was added after extraction before derivatization. The results of the three experiments were then averaged. The long-term quantitative (concentrations) and qualitative (retention indices) precision of selected compounds was good on both columns (Tables II and III). Ch.l: DB-5 Table III. Precision of Retention Indices Concentration Substance (pg/g) Column Mean RI* CV%* Desmethyldiazepam-TBDMS 0.2 DB DB Diazepam 0.2 DB D Temazepam-TBDMS 0.2 DB DB Midazolam 0.1 DB DB * Values are based on twelve runs during a lwelve-week period. Time (mln) Ch.2:DB-17 t; I I ~ Ch.l: DB-5 19 IT,,I ii 9 ~ 19 Tlme (mln) i i " A 2, Ch2:DB-17 ' f,,i iii i ' i Time (mln) Figure 2. The separation of the drugs (except chlordiazepoxide) and RI standards on DB-5 and DB-17 columns. Peak identification: 1,112; 2, diazepam; 3, desmethyldiazepam-tbdms; 4, R6; 5, clobazam; 6, midaolam; 7, norclobazam-tbdms; 8, flunitrazepam; 9, prazepam; 10, romazepam-tbdms; II, phenazepam-tbdms; 12, 118; 13, de smethylflunitrazepam.tbdms; 14, nitrazepam-tbdms; 15, oxazepam- TBDMS; 16, demoxepam-tbdms; 17, flurazepam; 18, temazepam- ~ BDMS; 19, 7-aminoclonazepam-TBDMS; 20, clonazepam-tgdms; 21, ormetazepam.tbdms; 22, lorazepam-tbdms; 23, alprazolam; 24, 1-hydro 25, triazolam; 26, brotizolam; 27, R12; 28, 1- hydroxyalprazolam-tbdms; 29, R14; 30, 1-hydroxytriazolam-TBDMS; and 31,1116. M Time (mln) Figure 3. A dual-column chromatogram obtained from an autopsy blood sample. The R series RI standards were co-injected with the sample. *** 9C-C~I~'e 9~m~:t [Vs:sl~ 1.30 *** Data rile : g827tthd.dta Ibt~xl : blmso:11,~ Ds~e C--eared : h~ A~g st; 00:29:33 Date Ana11,sed : hi Ik~ st 12:02:39 r cqz. ~ AleUt zdpaurs Dtt! J4x~ Aaount ~/g 1. ml~ndszd 92/n1"Z.9 1 1' @OO ' 5* duaet.bylr -*m T T O T, ,59T e~'~=~j M 1 15' O.00O 2?.0 t (I~11 IlellMm , ox~epaa-'11da T , ztanda.cd U 1 19' O * 9.T19 900,09 0, OO0... dasmm;~m*11: , tasslm~a*t]lqm 1 22 T.99T 8"/ O,OOI 4. a ~ 11t2 1 25* O O0 2 17' 14.9TT slp:ss01sa e~"~'~'4 P " * T O0 1-h,~lpzuollm ?ST et.aj~illrd * O.0O * O Figure 4. The SC-Compare report for the case in Fisure 3. 49
5 Figure 2 shows the separation of all compounds studied (except chlordiazepoxide) together with the co-injected R! standards on DB-5 and DB-17 columns. Figures 3 and 4 show the dual-column chromatogram from an actual autopsy blood sample and the SC-Compare analysis report for the case, respectively. Table IV. Compounds Tested for Interference Compound RI (DB-5) RI (DB-17) Amobarbital-TBDMS 196" ND ~ Brallobarbital-TBDMS 397' 193 Brompheniramine ND ND Butalbital-TBDMS 194 ND Carbamazepine-TBDMS Carbinoxamine ND ND Chlometiazole ND ND Chlormezanone Chloroquine-TBDMS Chlorpheniramine ND ND Chlorpromazine Chlorpropamide ND ND Chlorprothixene Chlorzoxazone ND ND Citalopram 402, , 737 Clobutinol ND ND Clomipramine ND ND Clozapine Cyclobarbital-TBDMS 478' 229* Diltiazem Felodipine Fenfluramine ND ND Flecainide-TBDMS Flumazenile Fluoxetine-TBDMS Fluvoxamine-TBDMS 507, , 341 Haloperidol Hexobarbital-TBDMS ND ND 10-Hydroxycarbamazepine-TBDMS Hydroxychloroquine-TB DMS Hydroxyzine-TBDMS Ketamine ND ND Lamotrigine-TBDMS 681,910' 800, 882* Meclozine Melperone ND ND Metoklopramide Moclobemide Moperone Nifedipine Oxcarbazepin-TBDMS 381, , 881 Parathion ND ND Pentobarbital-TBDMS 221 * ND Phenobarbital-TBDMS 444' 245* Phenytoin-TBDMS Secobarbital-TBDMS 269' ND 5ertraline-TBDMS Tiopental-TBDMS 223, 545, , 240 Trazodone Vinbarbital-TBDMS 236' ND Zopiclone * Fronting peak, which may disturb the integration of peaks eluting before the compound. Not detected inside the elution range of benzodiazepines. A selection of compounds that could be detected by ECD was tested for interference (Table IV). Although some of the compounds might be confused with benzodiazepines in a single column, none of them interfered with benzodiazepines in the present dual-column procedure. The results from the comparison study between the GC blood analysis and urine immunoassay are summarized in Table V. The following drugs were detected in those cases where the urine was negative and the blood positive: diazepar~ (18 times: range rag/l, desmethyldiazeparn (18: mg/l), oxazepam (13: mg/l), temazepa~ (19: rag/l), alprazolam (2:0.02 rag/l), and lorazepam (1:0.01 rag/l). In the cases where the urine was positive and the blood negative, both oxazepam and temazepam were found in urine in three cases, and in one case only oxazepam was found, as analyzed by GC-MS. The GC-MS analysis was performed by selected-ion monitoring, using three ions for each compound (oxazepam-tbdms: 457, 458, 459 and temazepam" TBDMS: 357, 359, 283) (5). The detailed examination of the two groups of cases is presented in Tables VI and VII. Discussion The dual-column technique using DB-5 and DB-170I columns has been proven to improve the reliability of the identification of unknown substances in GC drug screenin~l compared to a single-column technique (26). In the present study, the DB-17 column was used instead of DB-1701 be. cause the day-to-day precision of RIs on DB-1701 was poor. This is interesting because in our earlier studies with under" ivatized benzodiazepines the precision of RIs on a similar sta" tionary phase was very good (25). Depending on the compound, the RI values increased or decreased drastically during the 12-week period on DB-1701, unlike on DB-17, where the variation of RI values was smaller and more randor0. Also the detection limits of some compounds, especially 7" aminoclonazepam-tbdms, got higher during the 12-week pe. riod on DB Possibly, the excess of the silylation reagenl in the injection solvent reacted with the cyanopropyl groups of DB-1701 and changed the chemical composition of the sta' tionary phase. Table V. Comparison of Urine Immunoassay and Blood GC Results Urine (El'S) Blood (GC) No. of cases negative negative 284 positive positive 149 negative positive 48 positive negative 4 invalid' negative 26 invalid' positive 3 Total 514 ' No result obtained by ETS. J _.# 50
6 Although a few benzodiazepine compounds co-elute on one column (Figure 2), there is no pair of compounds that coelute on both columns. In practice, the only possible combination of benzodiazepines that may cause identification problems is the simultaneous presence of midazolam, oxazepam and nitrazepam. Oxazepam-TBDMS and nitrazepam- TBDMS co-elute on DB-5 and nitrazepam-tbdms and midazolam nearly co-elute on DB:17. Small amounts of nitrazepam may thus be missed. Of nonbenzodiazepine drugs, lamotrigine and some barbiturates, especially cyclobarbital, brallobarbital, and phenobarbital, produce big fronting peaks or a group of peaks and may thus disturb the integration of peaks eluting before them (Table IV). A disadvantage of the method is the fact that the amino Table Vl. Cases Where Urine was Negative by Immunoassay and Blood Positive by GC Case no. GC (blood)(ijg/g) Case history diazepam desmethyldiazepam desmethyldiazepam desmethyldiazepam 0.05, oxazepam diazepam 0.04, desmethyldiazepam oxazepam diazepam 0.02, desmethyldiazepam temazepam alprazolam diazepam 0.1, desmethyldiazepam 0.02, oxazepam desmethyldiazepam oxazepam temazepam desmethyldiazepam d iazepam 0.04, desmethyldiazepam diazepam 0.04, desmethyldiazepam 0.1, temazepam desmethyldiazepam diazepam 0.4, desmethyldiazepam 0.1, temazepam diazepam 0.07, desmethyldiazepam 0.06, temazepam temazepam 0.06, oxazepam temazepam diazepam 0.1, desmethyldiazepam 0.1, oxazepam 0.01, temazepam 0.01, lorazepam oxazepam temazepam diazepam 0.03 I019 diazepam diazepam 0.7, desmethyldiazepam 0.7, oxazepam 0.05, temazepam oxazepam temazepam temazepam temazepam temazepam diazepam 0.03, desmethyldiazepam oxazepam temazepam oxazepam diazepam temazepam temazepam temazepam diazepam 0.15, desmethyldiazepam desmethyldiazepam oxazepam diazepam 0.3, temazepam diazepam oxazepam alprazolam diazepam 0.02,,... died during an operation, resuscitated? hypothermia alcoholic, died in hospital suicide by poisoning (amitriptyline), died in hospital resuscitated suicide (train) traffic accident fracture of the skull, died abroad, embalmed heart disease fracture of the skull, treated 11 h in hospital bolus, ethanol 2.2 g/l, levomepromazine + fluoxetine died in health centre, ethanol 3.6 gll died while drinking alcohol, ethanol 3.5 gll unconscious, survived 12 h in hospital problem drinker, citalopram 4.7 mgll. (blood) suicide by poisoning (doxepin, propranolol), died in hospital heart disease heart disease heart disease bolus in psychiatric hospital suicide by hanging suicide by suffocation unconscious, died on the way to hospital, resuscitated?, drug user, poisoning (mianserin, propranolol, zopiclone, ethanol) suicide by poisoning (carbon monoxide), ethanol 2.8 g/l ethanol 2.6 g/l died in sauna, ethanol 3.5 g/l drowned diabetes, ethanol 3.4 g/l poisoning by ethylene glycol suicide by jumping from a balcony suicide by hanging suicide by shooting suicide by poisoning (citalopram, zopiclone, levomepromazine) suicide by poisoning (amitriptyline) suicide by hanging traffic accident, died in hospital, ethanol 3.0 gll, epilepsy, mentally handicapped suicide by shooting 51
7 groups of the amino metabolites of clonazepam and flunitrazeparn do not silylate in the present silylation procedure, and the detection limits of 7-arnino rnetabolites are high. 7-Aminoclonazeparn is included, but 7-aminoflunitrazeparn excluded from the screening. The detection of 7-aminonitrazeparn is not possible by EC detector because of the lack of an electron withdrawing group. No GC or GC-MS methods have been reported for the detection of all three 7-amino rnetabolites in the blood. However, HPLC methods are available (23,28). The quantitative precision results (Table II) are based on four determinations during a four-week period using a threepoint calibration and without recalibration during that time. To maintain the performance of the method, quantitative and qualitative calibration should be done at least once a month and the injector liner should be changed once a week. In addition, a few centimeters at the beginning of the column may be cut, if necessary, to maintain a good peak shape of triazoloor irnidazobenzodiazepines. One pair of columns can be used for the analysis of approximately 1400 blood extracts (four months of daily use in our laboratory). Although a few GC methods for screening benzodiazepines in blood have been published earlier, the dual-column approach with two different stationary phases has only been used once (19), and two similar columns with two different detectors (electron capture, nitrogen selective) were used twice (18,20). The quantitative precision of these methods has been generally well documented, and interfering compounds were tested in three papers (18-20), but the qualitative precision, implying the reliability of identification, is hardly discussed at all. The identification of compounds in two published methods was based on the relative retention time (19,20) and on the sole absolute retention time in three methods (16-18), but none of the methods used retention indices as the identification parameter. Although derivatization is widely used in GC-MS to improve the chromatographic properties of benzodiazepines, it has not been used in GC screening procedures in the blood. However, there is a target analysis for alprazolarn and rnetabolites after acylation (29). In the blood-urine comparison study, some of the bloodpositive and urine-negative results (Table VI) can be explained by a recently given dose during resuscitation. In most cases, however, the differences are due to different concentrations in the respective specimens and the performance of the analysis technique. It has been reported that enzymatic hydrolysis of glucuronide conjugates is required to ensure adequately sensitive detection of oxazeparn by EMIT d.a.u. (30) and oxazeparn, Table VII. Cases Where Urine was Positive by Irnrnunoassay and Blood Negative by GC Case no. GC-MS (urine) Case history 658 oxazepam, temazepam alcoholic, 718 oxazepam, temazepam 1118 oxazepam, temazepam homicide 1379 oxazepam jail death temazepam, and lorazepam by other immunoassays (31,32). In Table VI the blood benzodiazepine concentrations are, in all cases, at the therapeutic or subtherapeutic level and obviously have no contribution to the death. However, in crime-related cases, all drug findings may be significant. The four positive urine results in Table VII can be explained by the longer presence of the glucuronide conjugates in the urine than the parent drug in the blood. The results suggest that in postmortem forensic toxicology, benzodiazepines are more reliably detected in the blood by advanced GC methods than in urine by irnmunoassay. Furthermore, the GC method used allows simultaneous quantitation of the drugs. The blood drug concentrations are fairly low in many cases, and consequently, derivatization is required for high sensitivity. The results also reveal the widespread usage of benzodiazepines: 39.7% of the postmortem cases received for drug screening were positive for benzodiazepines. References I. H. Maurer and K. Pfleger. Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry. J. Chromatogr. 422: (1987). 2. S.J. Mule and G.A. Gasella. Quantitation and confirmation of the diazolo- and triazolobenzodiazepines in human urine by gas chromatography/mass spectrometry. J. Anal. Toxicol. 13: (1989). 3, P.H. Dickson, W. Markus, J. McKernan, and H.C. Nipper. Urinalysis of (z-hydroxyalprazolam, mhydroxytriazolam and other benzodiazepine compounds by GC/EIMS. J. Anal. Toxicol. 16" (1992). 4. W.A. Joern. Confirmation of low concentrations of urinary benzodiazepines, including alprazolam and triazolam by GC/MS: an ex, tractive alkylation procedure. ]. Anal. ToxicoL 16: (1992). 5. R.E. West and D.P. Ritz. GCIMS analysis of five common benzodiazepine metabolites in urine as tert-butyl-dimethylsilyl derivatives. J. Anal. Toxicol. 17:114-I 16 (I 993). 6. R.L. Fitzgerald, D.A. Rexin, and D.A. Herold. Benzodiazepine analysis by negative chemical ionization gas chromatography/mass spectrometry. ]. Anal. Toxicol. 17" (I 993). 7. D.A. Black, G.D. Clark, V.M. Haver, J.A. Garbin, and A.J. Saxon. Analysis of urinary benzodiazepines using solid-phase extraction and gas chromatography-mass spectrometry. J. Anal. Toxicol, 18: (1994). 8. L.E. Edinboro and A. Poklis. Detection of benzodiazepines and tribenzazolams by TRIAGETM: confirmation by solid-phase extraction utilizing SPEC microcolumns and GC-MS. ]. Anal. Toxicol. 18: (1994). 9. R. Meatherall. GC-MS confirmation of urinary benzodiazepine metabolites. ]. Anal. Toxicol. 18: (I 994). 10. R.L. Fitzgerald, D.A. Rexin, and D.A. Herold. Detecting benzo" diazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin. Chem. 40: (I 994). 11. C. Moore, G. Long, and M. Marr. Confirmation of benzodiazepine~ in urine as trimethylsilyl derivatives using gas chromatog" raphy/mass spectrometry. J. Chromatogr. B 655:132-I 37 (I 994). 12. S.B. Needleman and M. Porvaznik. Identification of parent ben" zodiazepines by gas chromatography/mass spectroscopy (GC/MS) from urinary extracts treated with l]-glucuronidase. Forensic 5ci. Int. 73:49-60 (I 995). 52
8 13. J.W. King and L.J. King. Solid-phase extraction and on-disc derivatization of the major benzodiazepines in urine using enzyme hydrolysis and Toxi-Lab VC MP3 column. J. Anal. Toxicol. 20: (1996). 14. J.L. Valentine, R. Middleton, and C. Sparks. Identification of urinan/benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens. J. Anal Toxicol. 20: (1996). 15. O. Beck, Z. Lin, K. Brodin, S. Borg, and P. Hjemdahl. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS. J. Anal. Toxicol. 21: (1997). 16. H.W. Peel and B.J. Perrigo. Toxicological analysis of benzodiazepine-type compounds in post-mortem blood by gas chromatography. J. Anal Toxicol. 4: (1980). 17. ].M.F. Douse. Trace analysis of benzodiazepine drugs in blood using deactivated amberlite XAD-7 porous polymer beads and silica capillary column gas chromatography with electron-capture detection. J. Chromatogr. 301: (1984). 18. p. Lillsunde and T. Sepp~l~i. Simultaneous screening and quantitative analysis of benzodiazepines by dual-column gas chromatography using electron-capture and nitrogen-phosphorus detection. J. Chromatogr. Biomed. Appl. 553: (1990). 19. H. Gjerde, E. Dahlin, and A.S. Christophersen. Simultaneous determination of common benzodiazepines in blood using capillary gas chromatography. J. Pharm. Biomed. Anal. 10: (1992). 20. y. Galliard, J.-P. Gay-Montchamp, and M. Ollagnier. Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction. J. Chromatogr Biomed. Appl. 622: (1993). 21. p. Mura, A. Piriou, P. Fraillon, Y.Papet, and D. Reiss. Screening procedure for benzodiazepines in biological fluids by high-performance liquid chromatography using a rapid-scanning multichannel detector. J. Chromatogr. Biomecl. Appl. 416: (1987). 22. E Mul~hoff and T. Daldrup. A rapid solid-phase extraction and HPLC/DAD procedure for the simultaneous determination and quantification of different benzodiazepines in serum, blood and post-mortem blood. Int. J. Leg. Med. 105: (1992). 23. I.A. Mclntyre, M.L. Syrjanen, K. Crump, S. Horomidis, A.W. Peace, and O.F. Drummer. Simultaneous HPLC analysis of 15 benzodiazepines and selected metabolites in postmortem blood. J. Anal. Toxicol. 17: (1993). 24. W. He, N. Parissis, and T. Kiratzidis. Determination of benzodiazepines in forensic samples by HPLC with photo-diode array detection. J. Forensic Sci. 43: (1998). 25. I. Rasanen, I. Ojanper~i, E. Vuori, and T.A. Hase. An homologous series of benzodiazepine retention index standards for gas chromatography. J. High Res. Chromatogr. 16: (1993). 26. I. Rasanen, I. Ojanper~i, J. Vartiovaara, E. Vuori, and P. Sunila. The advantage of dual-column approach and retention indices combined with refined reporting in gas chromatographic drug screening. J. High. Res. Chromatogr. 19: (1996). 27. L. Huber. Validation of analytical methods: review and strategy. LC-GC Int. 11(2): (1998). 28. M.D. Robertson and O.H. Drummer. High-performance liquid chromatographic procedure for the measurement of nitrobenzodiazepines and their 7-amino metabolites in blood. J. Chromatogr. Biomed. Appl. 667: (1995). 29. W.A. Joern and A.8. Joern. Detection of alprazolam (Xanax) and its metabolites in urine using dual column, dual nitrogen detector gas chromatography. J. Anal. Toxicol. 11: (1987). 30. O. Beck, P. Lafolie, G. Odelius, and L.O. Boreus. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol. Lett. 52:7-14 (1990). 31. P. Simonsson, A. Lid~n, and S. Lindberg. Effect of l~-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarization immunoassay. Clin. Chem. 41: (1995). 32. R. Meatherall. Benzodiazepine screening using EMIT ~ I1 and TDxe: urine hydrolysis pretreatment required. ]. Anal To 18: (1994). Manuscript received February 1, 1999; revision received April 26,
BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY
BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY Ilpo RASANEN, Mikko NEUVONEN, Ilkka OJANPERÄ, Erkki VUORI Department of Forensic Medicine, University of Helsinki, Helsinki,
More informationOverview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis
A Fast and Sensitive LC/MS/MS Method for the Quantification and Confirmation of 3 Benzodiazepines and Nonbenzodiazepine Hypnotics in Forensic Urine Samples Cliquid Software for Routine LC/MS/MS Analysis
More information4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column
Clinical, Forensic & Toxicology Applications 4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column By Amanda Rigdon Abstract A rapid, sensitive method
More informationEvaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites
Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites Valérie Thibert 1, Norbert Dirsch 2, Johannes Engl 2, Martin Knirsch 2 1 Thermo Fisher Scientific,
More informationApplication Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer
Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer Abstract This study demonstrates a sensitive, rapid and reliable research
More informationOffline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research
TECHNICAL NOTE 64913 Valium (diazepam) structure Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research Authors Claudio De Nardi,
More informationValidation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS
Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department
More informationAnalyze Drugs of Abuse with Agilent J&W Ultimate Plus Tubing in an Inert Flow Path
Analyze Drugs of Abuse with J&W Ultimate Plus Tubing in an Inert Flow Path Application Note Forensic Toxicology Author Ngoc A Dang Technologies, Inc. Abstract J&W Ultimate Plus deactivated fused silica
More informationImproving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology
Improving Benzodiazepine Immunoassay Sensitivity by Rapid Glucuronide Hydrolysis Technology Pongkwan (Nikki) Sitasuwan, Margarita Marinova, and L. Andrew Lee Integrated Micro-Chromatography Systems, LLC
More informationScreening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum
Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum NINA KANGAS, SIRPA MYKKÄNEN, SANNA KYLLÖNEN, PÄIVI RAJALA, KARI ARINIEMI
More informationDetection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System
Application Note Forensics, Workplace Drug Testing Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Authors Fred Feyerherm and Anthony Macherone Agilent Technologies, Inc.
More informationRapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1
Rapid Hydrolysis of Benzodiazepines in Urine Alicia Zook 1 and Crystal Xander B.S. 2 Cedar Crest College, Allentown, PA 1 Health Network Laboratories, Allentown, PA 2 Abstract: Benzodiazepines are sedative/hypnotic
More informationForensic Analysis of Blood Alcohol Concentration
Application Note Forensics Forensic Analysis of Blood Alcohol Concentration Using the Agilent 886 GC with Agilent J&W DB BAC1 UI and Agilent J&W DB-BAC2 UI columns and the Agilent 7697A headspace sampler
More informationE XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS
FORENSICS UCT E XCEL LENCE JUST GOT BETTER CLEAN SCREEN XCEL SPE COLUMNS CLEAN SCREEN XCEL COLUMNS EXTRACTION OF BASIC DRUGS AND METABOLITES FROM URINE/ BLOOD USING SPE CARTRIDGES 130mg Clean Screen Xcel
More informationA Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography
Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical
More informationDIRECT EXTRACTION OF BENZODIAZEPINE METABOLITE WITH SUPERCRITICAL FLUID FROM WHOLE BLOOD
DIRECT EXTRACTION OF BENZODIAZEPINE METABOLITE WITH SUPERCRITICAL FLUID FROM WHOLE BLOOD Kenichi TAKAICHI, Shuji SAITOH, Yoshio KUMOOKA, Noriko TSUNODA National Research Institute of Police Science, Chiba,
More informationFast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system
Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system Xiang He 1, Adrian Taylor 2 and Alexandre Wang 1 1 SCIEX, Redwood City, USA. 2 SCIEX, Concord,
More informationHigh-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine
High-Throughput Quantitative LC-MS/MS Analysis of and 14 Benzodiazepines in Urine Bill Yu, Kristine Van Natta, Marta Kozak, Thermo Fisher Scientific, San Jose, CA Application Note 588 Key Words Opiates,
More informationA Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS
A Rapid Method for Detection of Drugs of Abuse in Blood Samples Using the Thermal Separation Probe and the 5975T LTM GC/MS Application Note Forensics Authors Suli Zhao Agilent Technologies, Inc. Shanghai
More informationIdentification and Quantification of 22 Benzodiazepines in Postmortem Fluids and Tissues using UPLC/MS/MS
DOT/FAA/AM8/1 Office of Aerospace Medicine Washington, DC 291 Identification and Quantification of 22 Benzodiazepines in Postmortem Fluids and Tissues using UPLC/MS/MS Michael K. Angier Sunday R. Saenz
More informationDetermination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry
Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry Application Note Food Safety Authors Chenhao Zhai Agilent
More informationRapid and Robust Detection of THC and Its Metabolites in Blood
Rapid and Robust Detection of THC and Its Metabolites in Blood Application Note Forensics/Doping Control Author Stephan Baumann Agilent Technologies, Inc. Santa Clara CA 95051 USA Abstract A robust method
More informationScreening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System
Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System Ohtsuji M, Ohshima T, Takayasu T, Nishigami J, Kondo T, Lin Z, Minamino T Department of Legal Medicine,
More informationApplication. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology
Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS Application Forensic Toxicology Authors Christine Moore, Sumandeep Rana, and Cynthia Coulter Immunalysis Corporation 829 Towne Center Drive
More informationLC Application Note. Dangerous driver?
LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham
More informationSimultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS
Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS UCT Part Numbers CSXCE106 Clean Screen XCEL I 130mg / 6mL SPE Cartridge SPHACE5001-5 Select
More informationExtraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis
Application Note AN84 Extraction of -nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE SLE+ Page Extraction of -nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE SLE+
More information3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol
3-Acetyldeoxynivalenol 15-Acetyldeoxynivalenol [Methods listed in the Feed Analysis Standards] 1 Simultaneous analysis of trichothecene mycotoxin by gas chromatography [Feed Analysis Standards, Chapter
More informationDetermination of Bath Salts (Pyrovalerone Analogs) in Biological Samples
Determination of Bath Salts (Pyrovalerone Analogs) in Biological Samples Application Note Forensic Toxicology Authors Joe Crifasi Saint Louis University Forensic Toxicology Laboratory Saint Louis, Mo.
More informationAutomated Sample Preparation for Profiling Fatty Acids in Blood and Plasma using the Agilent 7693 ALS
Automated Sample Preparation for Profiling Fatty Acids in Blood and Plasma using the Agilent 7693 ALS Application Note Clinical Research Authors Frank David and Bart Tienpont, Research Institute for Chromatography,
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationApplication Note. Author. Abstract. Introduction. Food Safety
Determination of β2-agonists in Pork with SPE eanup and LC-MS/MS Detection Using Agilent BondElut PCX Solid-Phase Extraction Cartridges, Agilent Poroshell 120 column and Liquid Chromatography-Tandem Mass
More informationAutomated Targeted screening of Benzodiazepines in urine using LDTD-MS/MS at 400 samples per hour rate
Automated Targeted screening of Benzodiazepines in urine using LDTD-MS/MS at 400 samples per hour rate Pierre Picard, Alex Birsan, Serge Auger, Annie-Claude Bolduc and Jean Lacoursière Phytronix Technologies
More informationANALYSIS OF -HYDROXYBUTYRATE (GHB) AND -BUTYROLACTONE (GBL) IN LIQUIDS PERFORMED AT NATIONAL LABORATORY OF FORENSIC SCIENCE (SKL), SWEDEN
ANALYSIS OF -HYDROXYBUTYRATE (GHB) AND -BUTYROLACTONE (GBL) IN LIQUIDS PERFORMED AT NATIONAL LABORATORY OF FORENSIC SCIENCE (SKL), SWEDEN Per LUNDQUIST National Laboratory of Forensic Science, Linköping,
More informationPHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,
PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES DR. A. RAMESH, Ph.D, D.Sc., raamesh_a@yahoo.co.in 1 OBJECTIVES Determination of persistence and photolysis
More informationDetermination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples
Determination of Gamma-Hydroxy-Butyrate (GHB) in Biological Samples Application Note Forensic Toxicology Authors Joe Crifasi Saint Louis University Forensic Toxicology Laboratory Saint Louis, MO, USA Ron
More informationGC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants
GC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants Jeremy Matthews, 1 Alex Chen, 2 and Flavio Bedini 1 1 Thermo Fisher Scientific, Singapore; 2 Alpha Analytical Pte Ltd, Singapore Overview
More informationS. George* and R.A. Braithwaite Regional Laboratory for Toxicology, City Hospital NHS Trust, Dudley Road, Birmingham, England, B 18 7QH.
A Pilot Study to Determine the Usefulness of the Urinary Excretion of Methadone and its Primary Metabolite (EDDP) as Potential Markers of Compliance in Methadone Detoxification Programs S. George* and
More information[Application Note] TOXICOLOGY SCREENING BY UPLC/PDA IN COMBINATION WITH AN EXTENSIVE COMPOUND LIBRARY
TOXICOLOGY SCREENING BY UPLC/PDA IN COMBINATION WITH AN EXTENSIVE COMPOUND LIBRARY Camille Chatenay, 1,2 Fabien Bévalot, 1,2 Cyril Mounier, 1 Jean Michel Prévosto 1 1 Hôpital d Instruction des Armées Desgenettes,
More informationAnalysis of Organic Acids and Alcohols Using the Agilent J&W DB-624UI Ultra Inert GC Column
Analysis of Organic Acids and Alcohols Using the Agilent J&W DB-624UI Ultra Inert GC Column Application Note Food Testing & Agriculture Authors Pat Sasso and Ken Lynam Agilent Technologies, Inc. Abstract
More informationT2007 Seattle, Washington
T2007 Seattle, Washington Application of Liquid Chromatography-Mass Spectrometry with Atmospheric Pressure Chemical Ionization as a Screening Method for forty-two Date-Rape Drugs Piotr Adamowicz*, Maria
More informationA Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS
A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement
More informationFLUNITRAZEPAM Latest Revision: January 24, 2006
FLUNITRAZEPAM Latest Revision: January 24, 2006 1. SYNONYMS CFR: Flunitrazepam CAS #: 1622-62-4 Other Names: 5-(2-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H- 1,4-benzodiazepin-2-one Flunitrax Hipnosedon
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
More information[application note] Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS
Simultaneous detection and quantification of D 9 THC, 11-OH-D 9 T H C and D 9 THC-COOH in whole blood by GC tandem quadrupole MS Marie Bresson, Vincent Cirimele, Pascal Kintz, Marion Villain; Laboratoire
More informationAnalyze Barbiturates in Urine with Agilent 6430 LC/MS/MS and Poroshell 120 EC-C18
Analyze Barbiturates in Urine with Agilent 6 LC/MS/MS and Poroshell EC-C8 Application ote Forensic Toxicology Authors Elijah Steinbauer and Pat Friel Toxicology Laboratory at the Veterans Administration
More informationusing the Agilent 7696A Sample Prep
Automated Clean-up for Mineral Oil (Hydrocarbon Oil Index) Analysis using the Agilent 7696A Sample Prep WorkBench Application Note Automated Sample Preparation Authors Frank David, Karine Jacq, and Bart
More informationETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS
FORENSICS AND TOXICOLOGY ANALYSIS ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS Solutions for Your Analytical Business Markets
More informationRapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab
Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie
More informationHigh Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)
High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS) Michael Rummel, Matthew Trass, Michael Campognone, and Sky Countryman Phenomenex, Inc., 411 Madrid Avenue, Torrance,
More informationLCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching
Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple
More informationISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),
ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 2011, 8(3), 1275-1279 Simultaneous Determination of Paracetamol, Phenylephrine Hydrochloride, Oxolamine Citrate and Chlorpheniramine
More informationAmphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS
Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 643 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia
More informationProof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Robert M. Sears, Toxicology Technical Leader 1, Kenneth
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
More informationApplication Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.
Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice Application Note Author Food Syed Salman Lateef Agilent Technologies, Inc. Bangalore, India 8 6 4 2
More informationLyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
More informationAppNote 11/2008. Analysis of Drugs and Metabolites in Blood and Urine using Automated Disposable Pipette Extraction KEYWORDS ABSTRACT
AppNote 11/2008 Analysis of Drugs and Metabolites in Blood and Urine using Automated Disposable Pipette Extraction Fred Foster, Edward E. Pfannkoch, John R. Stuff, Jacqueline A. Whitecavage Gerstel, Inc.,
More informationLaboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
More informationQuantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer
application Note Liquid Chromatography/ Mass Spectrometry Authors Sharanya Reddy Blas Cerda PerkinElmer, Inc. Shelton, CT USA Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate
More informationA Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS
A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS By Shun-Hsin Liang and Frances Carroll Abstract Vitamin K₁ and K₂ analysis is typically complex and time-consuming because these
More informationLC-MS/MS Method for the Determination of Tenofovir from Plasma
LC-MS/MS Method for the Determination of Tenofovir from Plasma Kimberly Phipps, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 687 Key Words SPE, SOLA CX, Hypersil GOLD, tenofovir Abstract
More informationZolpidem in lethal cases
Zolpidem in lethal cases MARIE STAŇKOVÁ, PETR KURKA Institute of Forensic Medicine, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava-Poruba, Czech Republic Corresponding author: marie.stankova@fnspo.cz
More informationDETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS
FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications
More informationModified QuEChERS Procedure for Analysis of Bisphenol A in Canned Food Products
Modified QuEChERS Procedure for Analysis of Bisphenol A in Canned Food Products UCT Product Number: ECQUEU75CT-MP (pouch contains 4 mg MgSO 4, 1 mg NaCl, 5 mg Na citrate dibasic sesquihydrate, 1 mg Na
More informationAchieving Proposed Federal Concentrations using Reduced Specimen Volume for the Extraction of Amphetamines from Oral Fluid
Achieving Proposed Federal Concentrations using Reduced Specimen Volume for the Extraction of Amphetamines from Oral Fluid Christine Moore, Cynthia Coulter, and Katherine Crompton Immunalysis Corporation,
More informationUltrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System
Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System Application Note Forensic Toxicology Authors Nikunj R. Parikh, Michelle
More informationSELECTRA-SIL DERIVATIZING REAGENTS
Purpose of Derivatization: Derivatization is performed for two significant reasons. The first of which is to reduce the polarity and enhance the volatility of high molecular weight polar drugs, making
More informationDetermination of red blood cell fatty acid profiles in clinical research
Application Note Clinical Research Determination of red blood cell fatty acid profiles in clinical research Chemical ionization gas chromatography tandem mass spectrometry Authors Yvonne Schober 1, Hans
More informationRapid Analysis of 37 FAMEs with the Agilent 8860 Gas Chromatograph
Application Note Food Rapid Analysis of 37 FAMEs with the Agilent 88 Gas Chromatograph Author Youjuan Zhang Agilent Technologies (Shanghai) Co. Ltd., Shanghai 131 P. R. China Abstract An Agilent 88 GC
More informationDetermination of Benzodiazepines in Oral Fluid using LC MS MS
Determination of Benzodiazepines in Oral Fluid using LC MS MS Technical Note Christine Moore 1,*, Cynthia Coulter 1, Katherine Crompton 1, and Michael Zumwalt 2 1 Immunalysis Corporation, 829 Towne Center
More informationDetermination of Opiates and Metabolites in Blood Using Electrospray LC/MS. Application Note
Deteration of piates and Metabolites in Blood Using Electrospray LC/MS Application Note Scott A. Schlueter and James D. Hutchison, Jr. Montana Department of Justice, Division of Forensic Science John M.
More informationCore E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley
Core E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley This protocol describes the extraction and direct measurement of cholesterol esters (CEs) and triacylglycerols
More informationLC/MS/MS Analysis of Gabapentin, and Opiates. Applications. Presentation Outline. Polarity, MW and Volatility LC/MS Triple Quad Components
Presentation Outline LC/MS/MS Analysis of Gabapentin, LC/MS/MS Benzodiazepines, Introduction and Applications and Opiates Brian Nies LC/MS Product Specialist Varian Inc. Winter CAT Meeting Redondo Beach
More informationBETA-GLUCURONIDASE PRODUCT LINE INNOVATION THROUGH CHEMISTRY. FORENSICS
FORENSICS BETA-GLUCURONIDASE PROD LINE INNOVATION THROUGH CHEMISTRY ABALONASE Purified Beta-Glucuronidase Formula Clean, Rapid And Reliable Shown from left to right: Abalonase purified Beta-glucuronidase
More informationDetermination of Benzodiazepines in Urine by CE-MS/MS
Determination of Benzodiazepines in Urine by CE-MS/MS Application ote Forensic Toxicology Authors audimir Lucio do Lago Department of Fundamental Chemistry, Institute of Chemistry University of São Paulo,
More informationAnalysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ
Application Note Clinical Research Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ Authors Jennifer Hitchcock 1, Lauren Frick 2, Peter Stone 1, and Vaughn Miller 2 1 Agilent
More informationDetermination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS
Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS UCT Part Numbers XRDAH203 Gravity Flow XtrackT DAU 200 mg, 3 ml column SPHPHO6001-5 Select ph Buffer
More informationANALYSIS OF ESTAZOLAM IN POST-MORTEM MATERIAL
ANALYSIS OF ESTAZOLAM IN POST-MORTEM MATERIAL Ewa PUFAL 1, Marzena SYKUTERA 1, Grzegorz LIS 1, Gertrud ROCHHOLZ 2, Karol ŒLIWKA 1 1 Chair and Department of Forensic Medicine, Medical Academy, Bydgoszcz,
More informationDetermination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.
Page 1 of 10 Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection EPL-BAS Method No. 205G881B Method Summary: Residues of 6-CPA are
More informationApplication Note. Abstract. Authors. Pharmaceutical
Analysis of xycodone and Its Metabolites-oroxycodone, xymorphone, and oroxymorphone in Plasma by LC/MS with an Agilent ZRBAX StableBond SB-C18 LC Column Application ote Pharmaceutical Authors Linda L.
More informationAnalysis of Benzodiazepines in Alternate Matrices by HPLC. Overview
Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview Benzodiazepines/Class/Structure Benzodiazepine Metabolism/Elimination Biological Specimens Instrumentation Analytical Method Controls
More information1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
More informationAnalysis of several common. organic acids in tobacco leaf, snus, and moist snuff
Analysis of several common organic acids in tobacco leaf, snus, and moist snuff S. C. Moldoveanu, W. A. Scott R.J. Reynolds Tobacco Co. Background Among the organic acids commonly present in tobacco, are
More informationApplication. Authors. Abstract. Introduction. Forensics
Separation of Oxymorphone and Oxycodone Hydroxyl-imino Tri-methy Silyl Derivatives Using an Agilent Fast Toxicology Analyzer and an Agilent J&W DB-35ms Ultra Inert Capillary GC Column Application Authors
More informationFig. 1: Chemical structure of arachidonic acid COOH CH 3
Elimination of Matrix Effects Using Mixed-mode SPE Plate for High Throughput Analysis of Free Arachidonic Acid in Plasma by LC-MS/MS Wan Wang, Suzi Qin, Linsen Li, Warren Chen, Jerry Wang 179, Southern
More informationSimplified Gas Chromatographic Assay for Paracetamol
Ann. clin. Biochem. 12 (1975) 4 Simplified Gas Chromatographic Assay for Paracetamol M. J. STEWART AND R. G. WILLIS Department of' Clinical Chemistry, Ninewells Hospital and Medical School, Dundee, DD2
More informationAnalysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology
Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology Claude Mallet, 1 Jennifer Simeone, 2 Paul Rainville 3 1 Workflow Integration Group, Separations Technologies,
More informationHUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism
HUMAN LIVER SLICE EXPERIMENT 1 Effects of Propylene Glycol on Ethylene Glycol Metabolism Determination of Ethylene Glycol, Propylene Glycol, Oxalic Acid and Glycolic Acid BioReliance Study Number Testing
More informationFast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS
TECHNICAL NOTE 21883 Fast and easy separation of 23 drugs of abuse including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS Authors Kean Woodmansey 1, Jon Bardsley 1 and Stacy
More informationRapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System
Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System Xiang He, 1 Casey Burrows 1, Matthew Noestheden 2, Michael Jarvis, 2 Adrian Taylor,
More informationA Novel Reductive Transformation of Oxazepam to Nordiazepam
A Novel Reductive Transformation of Oxazepam to Nordiazepam Observed during Enzymatic Hydrolysis Shanlin Fu 1*, John Lewis 1, Hongjie Wang 2, Jim Keegan 1, and Michael Dawson 1 1 Department of Chemistry
More informationDetermination of β-hydroxybutyrate in Blood and Urine Using Gas Chromatography Mass Spectrometry
Determination of β-hydroxybutyrate in Blood and Urine Using Gas Chromatography Mass Spectrometry Huda M.A. Hassan* and Gail A.A. Cooper Forensic Medicine and Science, University of Glasgow, Glasgow G12
More informationTotal Morphine Stability in Urine Specimens Stored under Various Conditions
Total Morphine Stability in Urine Specimens Stored under Various Conditions Ber-Lin Chang, Min-Kun Huang, and Yu-Ying Tsai Division of Drug Chemistry, National Laboratories of Foods and Drugs, Department
More informationAuthor. Introduction. Abstract
Simultaneous Measurement of Sirolimus and Tacrolimus Concentrations in Blood by Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry Application Author Gary L.
More informationAuthors. Abstract. Introduction. Environmental
Determination of Ultratrace Amitrol in Water Samples by in situ Derivatization-Solid Phase Extraction-Liquid Chromatography-Mass Selective Detector Application Environmental Authors Gerd Vanhoenacker,
More informationExtraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS
Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS UCT Part Numbers SSHLD063 Styre Screen HLD 60 mg, 6 ml column SPHPHO6001-5 Select ph Buffer Pouches 100 mm Phosphate
More informationSPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine
SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine J. Jones, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 709 Key Words SPE, SOLA
More informationLC/MS Method for Comprehensive Analysis of Plasma Lipids
Application Note omics LC/MS Method for Comprehensive Analysis of Plasma s Authors Tomas Cajka and Oliver Fiehn West Coast Metabolomics Center, University of California Davis, 451 Health Sciences Drive,
More informationAbstract. Introduction
Highly Sensitive Micro-Plate Enzyme Immunoassay Screening and NCI-GC-MS Confirmation of Flunitrazepam and Its Major Metabolite 7-Aminoflunitrazepam in Hair'* Adam Negrusz 1,~, Christine Moore 2, Dawn Deitermann
More information